ANAGRELIDE for Polycythaemia vera: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 23 adverse event reports in the FDA FAERS database where ANAGRELIDE was used for Polycythaemia vera.
Most Reported Side Effects for ANAGRELIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 86 | 6.4% | 10 | 22 |
| Anaemia | 78 | 5.8% | 11 | 31 |
| Palpitations | 72 | 5.4% | 7 | 17 |
| Platelet count increased | 61 | 4.6% | 1 | 16 |
| Dyspnoea | 60 | 4.5% | 3 | 34 |
| Cardiac failure | 56 | 4.2% | 12 | 35 |
| Cerebral infarction | 52 | 3.9% | 8 | 34 |
| Off label use | 49 | 3.7% | 3 | 32 |
| Fatigue | 46 | 3.4% | 1 | 9 |
| Drug ineffective | 44 | 3.3% | 0 | 7 |
| Diarrhoea | 41 | 3.1% | 10 | 11 |
| Myelofibrosis | 41 | 3.1% | 1 | 3 |
| Oedema peripheral | 40 | 3.0% | 2 | 27 |
| Renal impairment | 36 | 2.7% | 3 | 9 |
| Skin ulcer | 36 | 2.7% | 2 | 9 |
Other Indications for ANAGRELIDE
Essential thrombocythaemia (797)
Product used for unknown indication (273)
Thrombocytosis (75)
Myeloproliferative neoplasm (23)
Platelet count increased (22)
Chronic myeloid leukaemia (15)
Janus kinase 2 mutation (13)
Thrombocytopenia (13)
Myelofibrosis (10)
Primary myelofibrosis (10)
Other Drugs Used for Polycythaemia vera
RUXOLITINIB (12,352)
ROPEGINTERFERON ALFA-2B-NJFT (1,011)
HYDROXYUREA (552)
PEGINTERFERON ALFA-2A (316)
PACRITINIB (112)
JAKAFI (81)
FEDRATINIB (69)
ASPIRIN (42)
LENALIDOMIDE (21)
PIPOBROMAN (17)